GlycoMimetics Inc expected to post a loss of 34  cents a share - Earnings Preview

Crescent Biopharma

01/03/2022 16:56

* GlycoMimetics Inc  GLYC.OQ   GLYC.O  is expected to show a
fall
in quarterly revenue when it reports  results on March 3. 
    * ​Refinitiv's mean analyst estimate for GlycoMimetics Inc
is for
a loss of 34 cents per share. For the same quarter last year,
the company reported a loss of 32 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
GlycoMimetics Inc
is $9​, about 86.3% above​ its last closing price of $1.23. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.32       -0.32      -0.34     Missed  -7.1
 Jun. 30 2021  -0.28       -0.31      -0.28     Beat    8.9
 Mar. 31 2021  -0.31       -0.32      -0.28     Beat    12​
 Dec. 31 2020  -0.32       -0.32      -0.32     Met     0.6
 ​​Sep.        -0.33       -0.33      -0.29     Beat    11.6
 30 2020                                                
 Jun. 30 2020  -0.38       -0.38      -0.32     Beat    15.8​
 Mar. 31 2020  -0.30       -0.30      -0.18     Beat    40.8
 Dec. 31 2019  -0.35       -0.35      -0.34     Beat    1.9
 This summary was machine generated March 1 at 16:56 GMT.  All
figures in US dollars  unless otherwise stated